{"news_desk": "Editorial", "print_page": "28", "section_name": "Opinion", "subsection_name": null, "byline": {"contributor": "", "original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial hails Food and Drug Administration's proposed simplified process for doctors to get experimental drugs for critically ill patients; holds their patients suffering life-threatening illnesses can only benefit from plan.", "type_of_material": "Editorial", "word_count": "602", "lead_paragraph": "A new proposal by the F.D.A. would simplify the process for doctors to obtain experimental drugs and greatly benefit desperately ill patients.", "pub_date": "2015-02-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Quicker Access to Experimental Drugs", "content_kicker": "Editorial", "print_headline": "Quicker Access to Experimental Drugs", "kicker": "Editorial"}, "snippet": "A new proposal by the F.D.A. would simplify the process for doctors to obtain experimental drugs and greatly benefit desperately ill patients.", "multimedia": [{"height": 126, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 450, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "450", "xlarge": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/02/12/opinion/quicker-access-to-experimental-drugs.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Doctors", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Clinical Trials", "name": "subject"}], "blog": [], "_id": "54dd1af038f0d8448bfa35ba", "source": "The New York Times"}